Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001145443-16-001794
Filing Date
2016-05-10
Accepted
2016-05-10 16:01:23
Documents
52
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d306831.htm 10-Q 1350326
2 EX-10.01 d306831_ex10-01.htm EX-10.01 25581
3 EX-31.01 d306831_ex31-01.htm EX-31.01 12752
4 EX-31.02 d306831_ex31-02.htm EX-31.02 11249
5 EX-32.01 d306831_ex32-01.htm EX-32.01 11421
  Complete submission text file 0001145443-16-001794.txt   4416655

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE biod-20160331.xml EX-101.INS 791621
7 XBRL CALCULATION FILE biod-20160331_cal.xml EX-101.CAL 26970
8 XBRL DEFINITION FILE biod-20160331_def.xml EX-101.DEF 116808
9 XBRL LABEL FILE biod-20160331_lab.xml EX-101.LAB 357691
10 XBRL PRESENTATION FILE biod-20160331_pre.xml EX-101.PRE 212749
11 XBRL SCHEMA FILE biod-20160331.xsd EX-101.SCH 37568
Mailing Address 100 SAW MILL ROAD DANBURY CT 06810
Business Address 100 SAW MILL ROAD DANBURY CT 06810 203-796-5000
Biodel Inc (Filer) CIK: 0001322505 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 161635643
SIC: 2834 Pharmaceutical Preparations